Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Cryo-EM structure of the bacterial actin AlfA reveals unique assembly and ATP-binding interactions and the absence of a conserved subdomain.

Usluer GD, DiMaio F, Yang SK, Hansen JM, Polka JK, Mullins RD, Kollman JM.

Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):3356-3361. doi: 10.1073/pnas.1715836115. Epub 2018 Feb 13.

PMID:
29440491
2.

International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module.

Rosenthal VD, Al-Abdely HM, El-Kholy AA, AlKhawaja SAA, Leblebicioglu H, Mehta Y, Rai V, Hung NV, Kanj SS, Salama MF, Salgado-Yepez E, Elahi N, Morfin Otero R, Apisarnthanarak A, De Carvalho BM, Ider BE, Fisher D, Buenaflor MCSG, Petrov MM, Quesada-Mora AM, Zand F, Gurskis V, Anguseva T, Ikram A, Aguilar de Moros D, Duszynska W, Mejia N, Horhat FG, Belskiy V, Mioljevic V, Di Silvestre G, Furova K, Ramos-Ortiz GY, Gamar Elanbya MO, Satari HI, Gupta U, Dendane T, Raka L, Guanche-Garcell H, Hu B, Padgett D, Jayatilleke K, Ben Jaballah N, Apostolopoulou E, Prudencio Leon WE, Sepulveda-Chavez A, Telechea HM, Trotter A, Alvarez-Moreno C, Kushner-Davalos L; Remaining authors.

Am J Infect Control. 2016 Dec 1;44(12):1495-1504. doi: 10.1016/j.ajic.2016.08.007. Epub 2016 Oct 11.

PMID:
27742143
3.

Impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Hand Hygiene Approach, over 8 years, in 11 cities of Turkey.

Leblebicioglu H, Koksal I, Rosenthal VD, Akan ÖA, Özgültekin A, Kendirli T, Erben N, Yalcin AN, Ulusoy S, Sirmatel F, Ozdemir D, Alp E, Yıldızdaş D, Esen S, Ulger F, Dilek A, Yilmaz H, Yýlmaz G, Kaya S, Ulusoy H, Tulunay M, Oral M, Ünal N, Turan G, Akgün N, İnan A, Ince E, Karbuz A, Çiftçi E, Taşyapar N, Güneş M, Ozgunes I, Usluer G, Turhan O, Gunay N, Gumus E, Dursun O, Arda B, Bacakoglu F, Cengiz M, Yilmaz L, Geyik MF, Şahin A, Erdogan S, Kılıc AU, Horoz OO.

J Infect Prev. 2015 Jul;16(4):146-154. doi: 10.1177/1757177414560249. Epub 2014 Dec 10.

4.

Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC).

Leblebicioglu H, Erben N, Rosenthal VD, Sener A, Uzun C, Senol G, Ersoz G, Demirdal T, Duygu F, Willke A, Sirmatel F, Oztoprak N, Koksal I, Oncul O, Gurbuz Y, Güçlü E, Turgut H, Yalcin AN, Ozdemir D, Kendirli T, Aslan T, Esen S, Ulger F, Dilek A, Yilmaz H, Sunbul M, Ozgunes I, Usluer G, Otkun M, Kaya A, Kuyucu N, Kaya Z, Meric M, Azak E, Yýlmaz G, Kaya S, Ulusoy H, Haznedaroglu T, Gorenek L, Acar A, Tutuncu E, Karabay O, Kaya G, Sacar S, Sungurtekin H, Uğurcan D, Turhan O, Kaya S, Gumus E, Dursun O, Geyik MF, Şahin A, Erdogan S, Ince E, Karbuz A, Çiftçi E, Taşyapar N, Güneş M.

Am J Infect Control. 2015 Jan;43(1):48-52. doi: 10.1016/j.ajic.2014.09.017.

PMID:
25564124
5.

Comparison of adefovir dipivoxil and pegylated interferon alpha-2a treatment in chronic hepatitis B patients.

Korkmaz P, Usluer G, Ozgunes I, Kartal ED, Erben N, Alpat SN.

North Clin Istanb. 2014 Aug 3;1(1):26-32. doi: 10.14744/nci.2014.27247. eCollection 2014.

6.

The features of infectious diseases departments and anti-infective practices in France and Turkey: a cross-sectional study.

Erdem H, Stahl JP, Inan A, Kilic S, Akova M, Rioux C, Pierre I, Canestri A, Haustraete E, Engin DO, Parlak E, Argemi X, Bruley D, Alp E, Greffe S, Hosoglu S, Patrat-Delon S, Heper Y, Tasbakan M, Corbin V, Hopoglu M, Balkan II, Mutlu B, Demonchy E, Yilmaz H, Fourcade C, Toko-Tchuindzie L, Kaya S, Engin A, Yalci A, Bernigaud C, Vahaboglu H, Curlier E, Akduman D, Barrelet A, Oncu S, Korten V, Usluer G, Turgut H, Sener A, Evirgen O, Elaldi N, Gorenek L.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1591-9. doi: 10.1007/s10096-014-2116-9. Epub 2014 May 1.

PMID:
24789652
7.

Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries.

Leblebicioglu H, Arama V, Causse X, Marcellin P, Ozaras R, Postawa-Klozinska B, Simon K, Suceveanu AI, Wiese M, Zeuzem S, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Zarski JP; AI463-121 European Longitudinal Chronic Hepatitis B Study Group.

J Viral Hepat. 2014;21(9):662-70. doi: 10.1111/jvh.12202. Epub 2013 Dec 15.

PMID:
24329883
8.

Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.

Sancak B, Yagci S, Gür D, Gülay Z, Ogunc D, Söyletir G, Yalcin AN, Dündar DO, Topçu AW, Aksit F, Usluer G, Ozakin C, Akalin H, Hayran M, Korten V.

BMC Infect Dis. 2013 Dec 10;13:583. doi: 10.1186/1471-2334-13-583.

9.

Fighting rabies in Eastern Europe, the Middle East and Central Asia--experts call for a regional initiative for rabies elimination.

Aikimbayev A, Briggs D, Coltan G, Dodet B, Farahtaj F, Imnadze P, Korejwo J, Moiseieva A, Tordo N, Usluer G, Vodopija R, Vranješ N.

Zoonoses Public Health. 2014 May;61(3):219-26. doi: 10.1111/zph.12060. Epub 2013 Jun 19.

PMID:
23782901
10.

Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010.

Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kübler A, Viet-Hung N, Ramírez-Wong FM, Portillo-Gallo JH, Toscani J, Gikas A, Dueñas L, El-Kholy A, Ghazal S, Fisher D, Mitrev Z, Gamar-Elanbya MO, Kanj SS, Arreza-Galapia Y, Leblebicioglu H, Hlinková S, Memon BA, Guanche-Garcell H, Gurskis V, Alvarez-Moreno C, Barkat A, Mejía N, Rojas-Bonilla M, Ristic G, Raka L, Yuet-Meng C; International Nosocomial Infection Control Consortiuma.

Infect Control Hosp Epidemiol. 2013 Jun;34(6):597-604. doi: 10.1086/670626. Epub 2013 Apr 18.

PMID:
23651890
11.

Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study.

Marcellin P, Arama V, Leblebicioglu H, Zarski JP, Zeuzem S, Mauss S, Sieklucki J, Acalovschi M, Usluer G, Klauck I, Morais E, Bjork S, Lescrauwaet B, Kamar D, Simon K; AI463-121 European Longitudinal Chronic Hepatitis B Study Group.

Antivir Ther. 2014;19(3):235-43. doi: 10.3851/IMP2573. Epub 2013 Apr 10.

PMID:
23574686
12.

A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.

Czajka H, Unal S, Ulusoy S, Usluer G, Strus A, Sennaroglu E, Guzik J, Topeli Iskit A, Dargiewicz A, Musial D, Caylan R, Dziduch J, Eskioglu E, Hasiec B, Cwinarowiczliwa E, Belli R, Abdel-Messih IA, Beygo J, Fragapane E.

J Prev Med Hyg. 2012 Sep;53(3):136-42. Erratum in: J Prev Med Hyg. 2012 Dec;53(4):220. Dosage error in published abstract; MEDLINE/PubMed abstract corrected.

PMID:
23362618
13.

Healthcare-associated infections and the distribution of causative pathogens in patients with diabetes mellitus.

Erben N, Ozgunes I, Aksit F, Doyuk Kartal E, Colak E, Usluer G.

Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):821-5. doi: 10.1007/s10096-013-1816-x. Epub 2013 Jan 25.

PMID:
23354673
14.

Clinical and Epidemiologic Characteristics of Hospitalized Patients with 2009 H1N1 Influenza Infection.

Nayman Alpat S, Usluer G, Ozgunes I, Doyuk Kartal E, Erben N.

Influenza Res Treat. 2012;2012:603989. doi: 10.1155/2012/603989. Epub 2012 Apr 23.

15.

Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C.

Usluer G, Erben N, Aykin N, Dagli O, Aydogdu O, Barut S, Cevik F, Ormen B; Study Group.

Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1873-8. doi: 10.1007/s10096-011-1513-6. Epub 2012 Jan 11.

PMID:
22231498
16.

Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey.

Prymula R, Usluer G, Altinel S, Sichova R, Weber F.

Adv Ther. 2012 Jan;29(1):41-52. doi: 10.1007/s12325-011-0090-5. Epub 2012 Jan 3.

PMID:
22228256
17.

Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs.

Erdem H, Tekin-Koruk S, Koruk I, Tozlu-Keten D, Ulu-Kilic A, Oncul O, Guner R, Birengel S, Mert G, Nayman-Alpat S, Eren-Tulek N, Demirdal T, Elaldi N, Ataman-Hatipoglu C, Yilmaz E, Mete B, Kurtaran B, Ceran N, Karabay O, Inan D, Cengiz M, Sacar S, Yucesoy-Dede B, Yilmaz S, Agalar C, Bayindir Y, Alpay Y, Tosun S, Yilmaz H, Bodur H, Erdem HA, Dikici N, Dizbay M, Oncu S, Sezak N, Sari T, Sipahi OR, Uysal S, Yeniiz E, Kaya S, Ulcay A, Kurt H, Besirbellioglu BA, Vahaboglu H, Tasova Y, Usluer G, Arman D, Diktas H, Ulusoy S, Leblebicioglu H.

Ann Clin Microbiol Antimicrob. 2011 Dec 16;10:38. doi: 10.1186/1476-0711-10-38.

18.

Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study.

Erdem H, Ulu-Kilic A, Kilic S, Karahocagil M, Shehata G, Eren-Tulek N, Yetkin F, Celen MK, Ceran N, Gul HC, Mert G, Tekin-Koruk S, Dizbay M, Inal AS, Nayman-Alpat S, Bosilkovski M, Inan D, Saltoglu N, Abdel-Baky L, Adeva-Bartolome MT, Ceylan B, Sacar S, Turhan V, Yilmaz E, Elaldi N, Kocak-Tufan Z, Ugurlu K, Dokuzoguz B, Yilmaz H, Gundes S, Guner R, Ozgunes N, Ulcay A, Unal S, Dayan S, Gorenek L, Karakas A, Tasova Y, Usluer G, Bayindir Y, Kurtaran B, Sipahi OR, Leblebicioglu H.

Antimicrob Agents Chemother. 2012 Mar;56(3):1523-8. doi: 10.1128/AAC.05974-11. Epub 2011 Dec 12.

19.

Report of the first meeting of the middle East and eastern europe rabies expert bureau, istanbul, Turkey (june 8-9, 2010).

Aylan O, El-Sayed AF, Farahtaj F, Janani AR, Lugach O, Tarkhan-Mouravi O, Usluer G, Vodopija R, Vranjes N, Tordo N, Dodet B.

Adv Prev Med. 2011;2011:812515. doi: 10.4061/2011/812515. Epub 2011 Sep 12.

20.

Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.

Guner R, Karahocagil M, Buyukberber M, Kandemir O, Ural O, Usluer G, Inan D, Koksal I, Baykam N, Hizel K, Yamazhan T, Esen S, Tasyaran MA.

Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1185-91. doi: 10.1097/MEG.0b013e32834ba13a.

PMID:
21934508

Supplemental Content

Loading ...
Support Center